Skip to main content
. 2020 Sep 9;27:100539. doi: 10.1016/j.eclinm.2020.100539

Table 2.

Chosen treatments by clinical scenario.

Treatment Clinical Scenario*
1 (n = 839) 2 (n = 842) 3 (n = 841) 4 (n = 840) 5 (n = 838)
Symptomatic treatment only,% 71 10 5 1 1
Chloroquine/Hydroxychloroquine,% 25 81 85 84 78
Lopinavir/Ritonavir,% 3 22 33 46 40
Azithromycin,% 14 50 60 62 57
Remdesivir,% 1 8 8 23 32
Interferon beta-1b/alfa-2,% 0 1 2 5 8
Low-dose corticosteroids,% 1 8 7 22 16
Pulse steroid therapy (>250 mg of methylprednisolone or equivalent),% 1 4 4 26 57
Empirical antibiotic therapy,% 2 1 29 48 54
Tocilizumab or another monoclonal antibody,% 1 4 4 33 72
Mean number of drugs (SD) 0.6 (1.2) 2.1 (1.3) 2.4 (1.2) 3.6 (1.4) 4.3 (1.4)

SCENARIO 1: Mildly symptomatic infection in an outpatient <65 years without comorbidity, without radiological involvement and with baseline oxygen saturation >95% on room air.

SCENARIO 2: Mildly symptomatic infection without pneumonia in a patient aged ≥65 years and/or comorbidity and/or oxygen saturation <95% on room air.

SCENARIO 3: Radiologically confirmed mild pneumonia, CURB-65 score pneumonia severity index ≤1 and oxygen saturation ≥95% on room air.

SCENARIO 4: Radiologically confirmed severe pneumonia who did not meet the ARDS criteria, CURB-65 score pneumonia severity index >1 and/or oxygen saturation <95% on room air.

SCENARIO 5: Severe pneumonia who met the ARDS criteria, CURB-65 score pneumonia severity index >1 and/or oxygen saturation <95% on room air.

Abbreviations: ARDS, acute respiratory distress syndrome; SD, standard deviation.